| __timestamp | Alpine Immune Sciences, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 94231000 |
| Thursday, January 1, 2015 | 16054000 | 146394000 |
| Friday, January 1, 2016 | 23316000 | 188272000 |
| Sunday, January 1, 2017 | 10626000 | 166707000 |
| Monday, January 1, 2018 | 28970000 | 401843000 |
| Tuesday, January 1, 2019 | 35847000 | 560909000 |
| Wednesday, January 1, 2020 | 27185000 | 722343000 |
| Friday, January 1, 2021 | 58742000 | 771182000 |
| Saturday, January 1, 2022 | 70243000 | 877090000 |
| Sunday, January 1, 2023 | 80904000 | 877387000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Sarepta's R&D expenses surged by over 830%, reflecting its aggressive pursuit of cutting-edge therapies. In contrast, Alpine Immune Sciences, while showing a steady increase, expanded its R&D budget by approximately 560% during the same period. This divergence highlights the varying strategies within the biotech sector, where some companies prioritize rapid growth and others adopt a more measured approach. As the industry continues to evolve, these spending patterns offer valuable insights into the future direction of biotech innovation.
Research and Development Investment: Eli Lilly and Company vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: AstraZeneca PLC vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Novartis AG and Alpine Immune Sciences, Inc.
GSK plc vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Grifols, S.A. and Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Alpine Immune Sciences, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?